BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Ovarian cancer AND ARNT, HIF1BETA, 405, ENSG00000143437, P27540, HIF-1beta, HIF1B, TANGO AND Diagnosis
15 results:

  • 1. The use of fertility treatments among reproductive-aged women after cancer.
    Kipling LM; Shandley LM; Mertens AC; Spencer JB; Howards PP
    Fertil Steril; 2024 Apr; 121(4):578-588. PubMed ID: 38103881
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Multi-Institutional Review of the Preoperative Diagnostic Accuracy for Pediatric ovarian Mature Cystic Teratomas.
    Knaus ME; Onwuka AJ; Afrazi A; Breech L; Corkum KS; Dillon PA; Ehrlich PF; Fallat ME; Fraser JD; Gadepalli SK; Grabowski JE; Hertweck SP; Kabre R; Lal DR; Landman MP; Lawrence AE; Leys CM; Mak GZ; Markel TA; Merchan N; Overman RE; Rademacher BL; Raiji MT; Rymeski B; Sato TT; Scannel M; Schikler AG; Sujka JA; Wright T; Aldrink JH; Hewitt GD; Minneci PC; Deans KJ;
    J Pediatr Adolesc Gynecol; 2022 Aug; 35(4):478-485. PubMed ID: 35124214
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Incidence of squamous cell carcinomas of the head and neck following prolonged pegylated liposomal doxorubicin.
    Rose PG; Fu F; Chambers LM; Mei L; De Bernardo R; Prendes BL; Lamarre E
    Anticancer Drugs; 2020 Aug; 31(7):747-750. PubMed ID: 32697468
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Risks of ovarian, breast, and corpus uteri cancer in women treated with assisted reproductive technology in Great Britain, 1991-2010: data linkage study including 2.2 million person years of observation.
    Williams CL; Jones ME; Swerdlow AJ; Botting BJ; Davies MC; Jacobs I; Bunch KJ; Murphy MFG; Sutcliffe AG
    BMJ; 2018 Jul; 362():k2644. PubMed ID: 29997145
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Is Omentectomy Mandatory Among Early Stage (I, II) Malignant ovarian Germ Cell Tumor Patients? A Retrospective Study of 223 Cases.
    Xu W; Li Y
    Int J Gynecol Cancer; 2017 Sep; 27(7):1373-1378. PubMed ID: 28520571
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The Value of Papanicolaou Tests in the diagnosis of Endometrial Carcinoma: A Large Study Cohort From an Academic Medical Center.
    Serdy K; Yildiz-Aktas I; Li Z; Zhao C
    Am J Clin Pathol; 2016 Mar; 145(3):350-4. PubMed ID: 27124917
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. HE4, CA125 and risk of ovarian malignancy algorithm (ROMA) as diagnostic tools for ovarian cancer in patients with a pelvic mass: An Italian multicenter study.
    Romagnolo C; Leon AE; Fabricio ASC; Taborelli M; Polesel J; Del Pup L; Steffan A; Cervo S; Ravaggi A; Zanotti L; Bandiera E; Odicino FE; Scattolo N; Squarcina E; Papadakis C; Maggino T; Gion M
    Gynecol Oncol; 2016 May; 141(2):303-311. PubMed ID: 26801941
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Efficacy of the echo pattern classification of ovarian tumors 2000 in conjunction with transvaginal ultrasonography for diagnosis of ovarian masses.
    Tajima A; Suzuki C; Kikuchi I; Kasahara H; Koizumi A; Nojima M; Yoshida K
    J Med Ultrason (2001); 2016 Apr; 43(2):249-55. PubMed ID: 26660908
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Changes in prevalence and clinical characteristics of cervical cancer in the People's Republic of China: a study of 10,012 cases from a nationwide working group.
    Li S; Hu T; Lv W; Zhou H; Li X; Yang R; Jia Y; Huang K; Chen Z; Wang S; Tang F; Zhang Q; Shen J; Zhou J; Xi L; Deng D; Wang H; Wang S; Xie X; Ma D
    Oncologist; 2013; 18(10):1101-7. PubMed ID: 24043599
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Assessment of CA-125 area under the curve as a prognostic factor in patients with ovarian cancer.
    Uzunoglu S; Aybatlı A; Kaplan PB; Cicin I; Sut N; Sayın C; Varol F
    Med Oncol; 2013 Mar; 30(1):447. PubMed ID: 23322523
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Autofluorescence imaging can identify preinvasive or clinically occult lesions in fallopian tube epithelium: a promising step towards screening and early detection.
    McAlpine JN; El Hallani S; Lam SF; Kalloger SE; Luk M; Huntsman DG; MacAulay C; Gilks CB; Miller DM; Lane PM
    Gynecol Oncol; 2011 Mar; 120(3):385-92. PubMed ID: 21237503
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Allelic imbalance in BRCA1 and BRCA2 gene expression and familial ovarian cancer.
    Shen J; Medico L; Zhao H
    Cancer Epidemiol Biomarkers Prev; 2011 Jan; 20(1):50-6. PubMed ID: 21119070
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Cyclin E expression is correlated with tumor progression and predicts a poor prognosis in patients with ovarian carcinoma.
    Rosen DG; Yang G; Deavers MT; Malpica A; Kavanagh JJ; Mills GB; Liu J
    Cancer; 2006 May; 106(9):1925-32. PubMed ID: 16568440
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Results of a standardized treatment concept in primary hyperparathyroidism].
    Funke M; Kim M; Hasse C; Bartsch D; Rothmund M
    Dtsch Med Wochenschr; 1997 Nov; 122(48):1475-81. PubMed ID: 9441136
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [Postmenopausal gynecologic pathology: 5-years activity at an ambulatory ultrasonography clinic].
    Leonardi M; Provenzale P; Bellicini G
    Minerva Ginecol; 1993 Oct; 45(10):485-8. PubMed ID: 8278080
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.